Pralsetinib showed robust and durable clinical activity with a well-tolerated safety profile in Chinese patients with RET fusion-positive non–small cell lung cancer (NSCLC) The most common grade 3/4 treatment-related adverse events in 68 patients were anemia (35.3%) and decreased neutrophil count (33.8%) As of March 4, 2022 (data cutoff), a confirmed objective response was observed… Continue reading Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer
Tag: Lung Cancer
Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer
Pralsetinib showed robust and durable clinical activity with a well-tolerated safety profile in Chinese patients with RET fusion-positive non–small cell lung cancer (NSCLC) The most common grade 3/4 treatment-related adverse events in 68 patients were anemia (35.3%) and decreased neutrophil count (33.8%) As of March 4, 2022 (data cutoff), a confirmed objective response was observed… Continue reading Efficacy and safety of pralsetinib in patients with advanced RET fusion‐positive non–small cell lung cancer
3 Questions: Sara Prescott on the brain-body connection
AI SummarySara Prescott, a faculty member in the Department of Biology at MIT, is researching the interoceptive nervous system and its role in detecting and responding to stimuli in the body. Her focus is on the mammalian airway and how neural pathways affect respiratory function and overall health. The goal of her research is to… Continue reading 3 Questions: Sara Prescott on the brain-body connection